Workflow
iShares US Consumer Discretionary ETF
icon
Search documents
Winter Storm Fern Freezes Q1 GDP — But ETFs Could Be Set Up For Spring Rebound
Benzinga· 2026-01-26 23:10
Winter Storm Fern is expected to deliver a sharp but temporary hit to U.S. economic growth, with Bank of America estimating a 0.5–1.5 percentage point drag on the first quarter 2026 GDP, according to Yahoo Finance. Drawing comparisons to Winter Storm Viola in 2021, the bank argues that most of the disruption reflects delayed economic activity rather than permanent demand destruction, and this is a critical distinction for investors.Extreme weather shocks can trigger brief rotations into defensive ETFs, incl ...
Uber, Amazon, Affiliated Managers Group And More On CNBC's 'Final Trades' - Affiliated Managers Group (NYSE:AMG), Amazon.com (NASDAQ:AMZN)
Benzinga· 2026-01-07 13:01
Group 1 - Amazon.com, Inc. was named as a final trade by Ritholtz Wealth Management's CEO, with a Buy rating maintained by Jefferies analyst and a price target increase from $275 to $300 [1] - Affiliated Managers Group, Inc. was selected as a final trade by Humilis Investment Strategies' CEO, supported by Goldman Sachs analyst maintaining a Buy rating and raising the price target from $300 to $341 [2] - iShares US Consumer Discretionary ETF was highlighted by NB Private Wealth's CIO, indicating positive consumer engagement as tariffs are no longer a concern [2] Group 2 - Uber Technologies, Inc. was chosen by Virtus Investment Partners' senior managing director, with shares gaining on the day [3] - Uber announced a renewal of its partnership with TomTom to enhance routing and location services for its operations [3] - Amazon shares rose 3.4% to close at $240.93, Affiliated Managers Group shares increased by 2.2% to $310.31, Uber shares surged around 6% to $85.54, and iShares US Consumer Discretionary ETF gained 0.9% [4]
Monolithic Power, Ascendis Pharma And More: CNBC's 'Final Trades' - Ascendis Pharma (NASDAQ:ASND), Goldman Sachs Nasdaq-100 Premium Income ETF (NASDAQ:GPIQ)
Benzinga· 2025-12-09 13:16
Company Insights - Ascendis Pharma A/S's New Drug Application (NDA) for TransCon CNP has had its review period extended by the FDA, with the new target action date set for February 28, 2026, due to a major amendment submitted on November 5 [2] - Ascendis Pharma's stock rose by 0.8% to close at $207.12 on Monday [6] Industry Trends - The consumer discretionary sector is showing signs of optimism, with growth expectations for the next year, as indicated by the selection of iShares US Consumer Discretionary ETF by NB Private Wealth [3] - Monolithic Power Systems Inc reported better-than-expected third-quarter results, with earnings of $4.73 per share surpassing the consensus estimate of $4.64, and sales of $737.176 million exceeding the estimate of $722.252 million [5] - Monolithic Power's shares gained 2.1% to close at $983.58 on Monday [6] Analyst Ratings - Morgan Stanley analyst Terence Flynn maintained an Overweight rating on Vertex and raised the price target from $516 to $564 [4]
IYC: Consumer Discretionary Dashboard For August
Seeking Alpha· 2025-08-20 12:00
Group 1 - The article provides a top-down analysis of the consumer discretionary sector, focusing on industry metrics related to value, quality, and momentum [1] - It aims to assist in analyzing sector ETFs, such as the iShares US Consumer Discretionary ETF [1] - The analysis is part of a monthly series that may highlight potential investment opportunities within the sector [1] Group 2 - The author, Fred Piard, has over 30 years of experience in technology and has been investing in data-driven systematic strategies since 2010 [1] - Fred runs an investing group that shares a portfolio invested in quality dividend stocks and companies at the forefront of tech innovation [1] - The author also provides market risk indicators and various investment strategies, including real estate, bonds, and closed-end funds [1]